| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Nortramadol | LP18113-8 |
| PROPERTY | PrThr | LP217195-9 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Ord | LP7751-3 |
| METHOD_TYP | Confirm | LP6197-0 |
| parent | Nortramadol | Serum or Plasma | Drug toxicology | LP388633-2 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both |
| LONG_COMMON_NAME | en-US | Nortramadol [Presence] in Serum or Plasma by Confirmatory method |
| LONG_COMMON_NAME | en-US | Nortramadol [Presence] in Serum or Plasma by Confirmatory method |
| SHORTNAME | en-US | Nortramadol SerPl Ql Cfm |
| ConsumerName | en-US | Nortramadol, Blood |
| SHORTNAME | es-AR | nortramadol:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal:confirmación |
| SHORTNAME | pt-BR | Nortramadol SerPl Ql Cfm |
| LONG_COMMON_NAME | fr-FR | Nortramadol [Présence/Seuil] Sérum/Plasma ; Qualitatif ; Confirmation |
| LONG_COMMON_NAME | nl-NL | Nortramadol [aanwezigheid] in serum of plasma d.m.v. bevestiging |
| LONG_COMMON_NAME | es-MX | Nortramadol: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: Confirmar |
LOINC Version: 2.77
FHIR